强直性脊柱炎疾病活动度评分（ASDAS）：疾病活动状态命名法2018年更新版 - Suppr

Suppr

超能文献

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states.

作者信息

Machado Pedro M, Landewé Robert, Heijde Désirée van der

机构信息

Centre for Rheumatology and MRC Centre for Neuromuscular Diseases, University College London, London, UK.

Department of Rheumatology, Academic Medical Center Amsterdam, Heerlen, The Netherlands.

出版信息

Ann Rheum Dis. 2018 Oct;77(10):1539-1540. doi: 10.1136/annrheumdis-2018-213184. Epub 2018 Feb 16.

DOI:10.1136/annrheumdis-2018-213184

PMID:29453216

Abstract

摘要

相似文献

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states.

Ann Rheum Dis. 2018 Oct;77(10):1539-1540. doi: 10.1136/annrheumdis-2018-213184. Epub 2018 Feb 16.

The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.

J Clin Rheumatol. 2017 Aug;23(5):267-272. doi: 10.1097/RHU.0000000000000522.

Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.

Ann Rheum Dis. 2014 Jul;73(7):1350-5. doi: 10.1136/annrheumdis-2012-202976. Epub 2013 May 24.

Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.

Rheumatol Int. 2015 Jun;35(6):981-9. doi: 10.1007/s00296-014-3168-y. Epub 2014 Nov 4.

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.

Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594. Epub 2010 Nov 10.

Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.

Int J Rheum Dis. 2019 Dec;22(12):2206-2212. doi: 10.1111/1756-185X.13735. Epub 2019 Nov 13.

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.

Health Qual Life Outcomes. 2014 Aug 22;12:129. doi: 10.1186/s12955-014-0129-9.

Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.

Scand J Rheumatol. 2024 May;53(3):180-187. doi: 10.1080/03009742.2023.2213509. Epub 2023 Jun 20.

[Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].

Reumatizam. 2012;59(1):5-10.

A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.

Clin Rheumatol. 2012 Nov;31(11):1599-603. doi: 10.1007/s10067-012-2056-7. Epub 2012 Aug 16.

引用本文的文献

Serum Catestatin Levels and Its Relationship with Disease Activity in Patients with Ankylosing Spondylitis.

Arch Rheumatol. 2025 Jun 23;40(2):157-163. doi: 10.5152/ArchRheumatol.2025.11014.

Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh.

Cureus. 2025 Jun 17;17(6):e86211. doi: 10.7759/cureus.86211. eCollection 2025 Jun.

Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trial.

RMD Open. 2025 Jul 15;11(3):e005525. doi: 10.1136/rmdopen-2025-005525.

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries.

BMC Rheumatol. 2025 Jul 11;9(1):88. doi: 10.1186/s41927-025-00529-4.

Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.

J Clin Med. 2025 Jun 10;14(12):4111. doi: 10.3390/jcm14124111.

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry.

BMC Rheumatol. 2025 May 27;9(1):62. doi: 10.1186/s41927-025-00510-1.

Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis.

Arthritis Care Res (Hoboken). 2025 May 2. doi: 10.1002/acr.25565.

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Rheumatol Adv Pract. 2025 Jan 29;9(2):rkaf012. doi: 10.1093/rap/rkaf012. eCollection 2025.

Comparison of Retinal Microvascular Changes in Axial Spondyloarthritis Using Optical Coherence Tomography Angiography: Anti-TNF vs. NSAID Therapy.

Diagnostics (Basel). 2025 Mar 1;15(5):597. doi: 10.3390/diagnostics15050597.

Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.

RMD Open. 2025 Feb 20;11(1):e004844. doi: 10.1136/rmdopen-2024-004844.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验